Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01272739 · ClinicalTrials.gov registry record · Phase 2
Randomized Study to Evaluate the Effect of an Investigational Product on Weight Loss and Body Composition
A Phase 2 study, sponsored by Avera McKennan Hospital & University Health Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT01272739: Completed Phase 2 study, sponsored by Avera McKennan Hospital & University Health Center.
NCT01272739 is a Phase 2 study that has completed, run by Avera McKennan Hospital & University Health Center. The registered enrollment target is 10 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01272739, a Phase 2 study, has completed, sponsored by Avera McKennan Hospital & University Health Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
This is a pilot study to determine the safety and efficacy of an investigational product (IHBG-10) on weight loss, and changes in body composition.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT IHBG-10
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2011-02 |
| Est. Completion | 2011-07 |
| Phase | Phase 2 |
What the finished NCT01272739 record still lists
NCT01272739 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01272739 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01272739 about?
NCT01272739 is a clinical study titled "Randomized Study to Evaluate the Effect of an Investigational Product on Weight Loss and Body Composition". This is a pilot study to determine the safety and efficacy of an investigational product (IHBG-10) on weight loss, and changes in body composition.
What is the current status of trial NCT01272739?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2011-02. Estimated completion is 2011-07.
What interventions are being tested in trial NCT01272739?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), IHBG-10 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01272739?
This trial is sponsored by Avera McKennan Hospital & University Health Center, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01272739's enrollment target sits among peer trials
10 1968th of 2000 higher than 12 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia